
Piper Review
Best for: mainstream telehealth GLP-1 access
Telehealth weight loss provider offering competitively priced compounded GLP-1 medications.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Piper is a solid telehealth option with balanced features and pricing.
Piper at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $135/mo
- Pricing model
- Flat — dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored Piper
Each dimension is scored algorithmically from Piper’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
8.2/10At $135/mo, Piper runs about 20% below the $170 median for GLP-1 providers. Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
7.9/10Piper offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
6.8/10Online intake and platform experience — consult included in the price; 3 platform features disclosed.
Trust & Safety15%
7.9/10Key details fully confirmed by our editors; no FDA warning letters on file (last checked 2026-06-03).
Accessibility10%
8.0/10Piper treats patients in all 50 states.
Support10%
5.6/10Piper provides standard clinician follow-up; no extended coaching or community program is disclosed.
How we verified this Piper review
Last checked 2026-06-03- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: high.
GLP-1 medications Piper offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Ready to get started?
Plans and promotions change often — check Piper's current pricing and active discounts before you decide.
What we like
- Aggressively low monthly pricing
- Both semaglutide and tirzepatide available
- Compounded GLP-1 access
Watch-outs
- Limited public information on program details
Piper: a low flat rate for compounded GLP-1s, with a name change to watch
Piper is a no-frills telehealth program built around one idea: charge the same low price for your compounded GLP-1 every month, no matter what dose you climb to. Compounded semaglutide starts at $135 a month and compounded tirzepatide runs a bit under two hundred dollars a month, and that figure is meant to be the whole bill, not a teaser. If you want cheap, predictable access to compounded medication and you don't need a lot of hand-holding or brand-name options, Piper is worth a look. The catch is that it publishes very little about how the program actually runs day to day, and it is in the middle of rebranding to Polly, so the name on your account and your shipping box may not match the one you signed up under.
How the flat pricing really works
Most compounding telehealth programs quietly raise your monthly cost as your dose increases, so the price you see at signup is rarely the price you pay six months in. Piper's model is the opposite: it advertises the same price for every dose, with no membership tier layered on top and no separate consult charge. The medication, the clinician visit, and shipping are all folded into that single monthly number. For semaglutide that means $135 a month from your first low dose through your maintenance dose; tirzepatide sits a little higher but follows the same flat structure.
For comparison, the category median for this kind of program lands around $170 a month, so Piper's semaglutide rate is meaningfully below the middle of the pack. That makes it one of the more aggressively priced options we track. Just remember this is self-pay only — Piper does not bill insurance — though it does say you can submit for HSA or FSA reimbursement, which softens the out-of-pocket sting for some people.
- Same price at every dose — no step-ups as you titrate
- No membership fee and no separate consultation charge
- Free next-day air shipping included in the monthly price
- Self-pay only, with HSA/FSA reimbursement available
What you get and how it ships
Piper offers compounded versions of both major GLP-1 molecules: semaglutide (the active ingredient in Ozempic and Wegovy) and tirzepatide (the active ingredient in Mounjaro and Zepbound). These are compounded formulations from a pharmacy, not the branded pens — so if having a brand-name product specifically matters to you, this isn't the provider for that. One genuinely nice operational detail is shipping: Piper advertises free next-day air, which is faster than the standard ground shipping most budget programs use, and it says the program is available in all 50 states through clinicians licensed where you live.
The rebrand you should know about
The most important thing to flag isn't pricing — it's identity. Piper is rebranding to Polly. The corporate entity behind it, Piper Wellness LLC, is now doing business as JoinPolly, and the website itself states that 'Piper is now Polly.' Practically, that means emails, your patient portal, payment descriptors, and packaging may show 'Polly' rather than 'Piper.' That isn't a red flag on its own — companies rename all the time — but if you're the type to worry about an unfamiliar charge or an unexpected sender, know in advance that the two names refer to the same operation.
Where Piper falls short
Our biggest reservation is transparency. Piper publishes the price and the basics, but it shares little detail about the specifics that careful patients care about: which compounding pharmacy fills the prescription, how clinical oversight and dose adjustments are handled, what the refund or cancellation terms are, and how side effects are managed between visits. We could not verify a named, accredited compounding partner for Piper, and the company doesn't spell out its medical-supervision model the way more established programs do. None of that is evidence of a problem, but it does mean you're trusting a lean, thinly documented program. There are no FDA warning letters on file against it, which is reassuring as far as it goes.
Who it's for — and who should skip it
Choose Piper (or Polly) if your priority is the lowest reasonable monthly price for compounded semaglutide or tirzepatide, you're comfortable with a self-pay, compounded-only model, and you don't need extensive coaching, lab work, or brand-name medication baked in. Skip it if you want brand-name pens, insurance billing, a clearly documented pharmacy and clinical team, or a high-touch program with nutrition and coaching support — other providers spell those things out far more clearly. You can see how we weigh price, transparency, and oversight in our scoring methodology.
Bottom line
Piper is a budget-first compounded GLP-1 program with a genuinely attractive hook: a flat monthly price that doesn't climb as your dose does, plus fast included shipping in all 50 states. For cost-conscious patients who know they want a compounded medication and don't need extras, that's a strong, simple value. Just go in clear-eyed about the two trade-offs — the limited public information on how the program is run, and the active rebrand to Polly — and confirm the current price and terms directly before you enroll.
If you're weighing alternatives, Oak ($130/month) and bmiMD ($99/month) are among the closest options we track to Piper.
Ready to start with Piper?
Starting at $135/month. See current pricing and start your free consultation.
Alternatives to Piper
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Piper review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with Piper?
Starting at $135/month. See current pricing and start your free consultation.